Description
An orally available inhibitor of microtubule polymerization (IC50 = ~3 µM) that blocks cell cycling at the G2-M phase, which leads to cell death; cytotoxic to a range of cancer cell lines (IC50s = 9-101 nM) and demonstrates antivascular activity in tumors both in vitro and in vivo
Formal name: N-ethyl-N’-[2-methoxy-4-[5-methyl-4-[[(1S)-1-(3-pyridinyl)butyl]amino]-2-pyrimidinyl]phenyl]-urea
Synonyms: Lexibulin
Molecular weight: 434.5
CAS: 917111-44-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Microtubule Dynamics||Research Area|Cancer|Angiogenesis||Research Area|Cancer|Cell Cycle|G2/M||Research Area|Cancer|Cell Death||Research Area|Cell Biology|Cytoskeleton & Motor Proteins